Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The early asexual intracellular stages of apicomplexan parasites, such as Plasmodium falciparum and Toxoplasma gondii, are critical phases of infection characterized by rapid replication within host cells like red blood cells or hepatocytes (CDC, 2024). These stages include the ring and trophozoite forms in malaria, where the parasite actively consumes host hemoglobin and undergoes significant metabolic expansion (Nature Reviews Microbiology, 2013). Targeting these stages is the cornerstone of antimalarial therapy, as they are responsible for the clinical symptoms of the disease (NIH, 2023). Drugs like artemisinins and chloroquine act by disrupting parasite homeostasis or heme detoxification during these specific intracellular phases (PubMed, 2021). Because this target represents a complex biological stage rather than a single protein, it encompasses numerous potential molecular targets, including the apicoplast, the food vacuole, and various transporters (StatPearls, 2023). Therapeutic challenges include the rapid development of drug resistance and the need for stage-specific activity to achieve complete clearance (WHO, 2023).
Drugs targeting these stages typically inhibit essential parasite processes such as heme detoxification, DNA synthesis, mitochondrial electron transport, or protein synthesis within the apicoplast (Nature Reviews Microbiology, 2013).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Early asexual intracellular stages of apicomplexan parasites.